Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women
Marjanka K. Schmidt(University of Cambridge), Laura van ‘t Veer, Jelle Wesseling(Leiden University Medical Center), Maryska L.G. Janssen‐Heijnen(Leiden University Medical Center), Flora E. van Leeuwen(The Netherlands Cancer Institute), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), Alexandra J. van den Broek(The Netherlands Cancer Institute), Pieter J. Westenend(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Agnes Jager(Erasmus MC Cancer Institute), Wolter Oosterhuis(Leiden University Medical Center), Jan J. Jobsen(Medisch Spectrum Twente), Adri C. Voogd(Maastricht University Medical Centre), Vincent T.H.B.M. Smit(Leiden University Medical Center), Mariël Brinkhuis(Leiden University Medical Center)
Cited by 85
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
|New England Journal of Medicine|2004|1.7k
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
|Nature Genetics|2013|1.1k